The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the ...

One major difference between re-entrant and non– re-entrant ventricular tachycardia (VT) is that the electrophysiological substrate for re-entry is acquired during postnatal development and is due to ...

Given advances in antiretroviral therapy, the mortality rate for HIV infection has dropped considerably over recent decades. However, people living with HIV (PLWH) experience longer life spans coupled ...

The adult mammalian heart has limited endogenous regenerative capacity and heals through the activation of inflammatory and fibrogenic cascades that ultimately result in the formation of a scar. After ...

WORLD OF EVS EVs are 30- to 1000-nm-sized membranous structures released by cells into the extracellular space (Figure 1). Their membrane, composed of a complex lipid and protein repertoire, ...

Pathological cardiac hypertrophy stands as a pivotal mechanism contributing to diverse cardiovascular diseases, ultimately leading to heart failure. Despite its clinical significance, the intricate ...

Background— Pulmonary hypertension (PH) is a severe disease with a poor prognosis. Different forms of PH are characterized by pronounced vascular remodeling, resulting in increased vascular resistance ...

Areas for Further Research...629 References...630 Appendix A Coronary Artery Revascularization Measure Set...636 Performance Measures for Coronary Artery Revascularization...636 Short Title: PM-1: Use ...

Methods Patients with cardiogenic shock supported by Impella CP in an Asian tertiary cardiac center were evaluated for 30‐day post percutaneous ventricular assist device (PVAD) survival after adopting ...

Left heart disease (LHD) affects ≈10% of the population over the age of 20 years in the United States with coronary disease as the leading cause of death. 1 Heart failure (HF)—the end result of ...

Background Transcarotid artery revascularization (TCAR) was approved by the Food and Drug Administration in 2015 for patients with carotid artery stenosis. However, no randomized trial to evaluate ...

Background: Dilated cardiomyopathy (DCM) was considered a monogenetic disease that can be caused by over 60 genes. Evidence suggests that the combination of multiple pathogenic variants leads to ...